Xiaogan Central Hospital recently introduced the globally advanced SHURUI^® single-port surgical robot, marking a milestone in minimally invasive surgery and the commercial adoption of high-end domestic medical technology in a prefecture-level hospital.

Soon after deployment and training, the surgical team independently performed the  single-port robotic surgeries. Led by Director Zhuo Wei from Urology, the team completed a textbook-level left kidney tumor resection and a right kidney cyst removal through a single tiny incision using the SHURUI^® robot’s three flexible snake arms and 2.5cm sheath.

Both surgeries featured minimal bleeding, rapid patient recovery, and significantly reduced pain and infection risks. The procedures demonstrate SHURUI^® robot’s superior precision and flexibility in complex anatomical regions, advancing Xiaogan’s medical technology to new heights.

Director Wei highlighted the robot’s expanded surgical field, enhanced dexterity, and improved patient outcomes, reinforcing the hospital’s confidence in promoting this innovative technology.

With strong leadership support and cross-department collaboration, Xiaogan Central Hospital plans to expand SHURUI^® robot applications across multiple specialties, bringing cutting-edge, minimally invasive treatment to more patients.